Patients with coronary artery disease undergoing percutaneous coronary intervention
Conditions
Interventions
Sponsors
Medisch Centrum Leeuwarden,
Cardiologie poli 67
Henri Dunantweg 2
8934 AD Leeuwarden
The Netherlands
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient is willing to sign the informed consent; 2. Patient is willing to perform all follow-up examinations as required by the protocol; 3. Patient eligible for coronary revascularization intervention by PCI and stenting; 4. Patient is located in a geographic area that will enable contact by the study site for follow-up.
Exclusion criteria
Exclusion criteria: 1. Patients who are minor, intravenous drug abusers, alcohol abuser, prisoners or unable to give informed consent; 2. Patients who are allergic to everolimus or sirolimus; 3. Patients with known intolerance or contra-indications to treatment with acetylsalicylic acid or clopidogrel; 4. Patients in whom the cardiologist judges that stent implantation is not possible, realistic or justified.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical MACE at 1 year (cardiac mortality, non-fatal myocardial infarction, TVR). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. (Sub)-acute stent thrombosis (SAT) at 30 days and late stent thrombosis (LST) at 1, 2 and 3 year; 2. Clinical MACE at 30 days and 2 and 3 years (cardiac death, non-fatal MI, TVR); 3. All cause mortality at 1, 2 and 3 year. | — |
Contacts
Public ContactA.J. Boven, van
Afd. Cardiologie Henri Dunantweg 2
Outcome results
None listed